Fayez Sarofim & Co
VRTX icon

Fayez Sarofim & Co’s Vertex Pharmaceuticals VRTX Stock Holding History

Fayez Sarofim & Co’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$4.61M Sell
10,358
-34
-0.3% -$15.1K 0.01% 130
2025
Q1 		$5.04M Hold
10,392
– – 0.01% 123
2024
Q4 		$4.18M Buy
+10,392
New +$4.18M 0.01% 129